{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study defines Parkinson's disease as a multi-functional protein with loss of function leading to disease onset.",
          "judgment": "Yes",
          "reasoning": "The functional evidence is directly tied to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assays (heterodimerization, proteasome inhibitor stability, and H2O2 scavenging) model pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The assays are applicable to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type, mutant, and wild-type with loss of function) were used in the studies.",
          "judgment": "Yes",
          "reasoning": "Validated and replicable in the field."
        },
        {
          "next_step_or_outcome": "Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "PS3_very_strong",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence strongly supports the pathogenicity of the mutations, as they are directly linked to disease mechanisms."
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "117"
        },
        "variant_string_id": "CFTR R117H"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study links CFTR mutations to cancer and pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Benign mutations are directly linked to disease mechanisms."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Assays (protein interaction, H2O2 scavenging) model benign outcomes.",
          "judgment": "Yes",
          "reasoning": "Assays are applicable to benign outcomes."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type, mutant, and wild-type with loss of function) were used.",
          "judgment": "Yes",
          "reasoning": "Validated and replicable in the field."
        },
        {
          "next_step_or_outcome": "Step 4"
        }
      ],
      "final_evidence_strength": {
        "type": "BS3_moderate",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The functional evidence is moderate in pathogenicity, as it supports benign mutations."
    }
  ]
}